NCT05945927 2025-10-10A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast CancerHoffmann-La RocheCompleted178 enrolled